Early Immunotherapy with Intravenous Immunoglobulin, Cyclophosphamide and Methylprednisolone in Patients with Anti-Hu-associated Paraneoplastic Sensory Neuronopathy

Clinical trial NCT06373211 · RECRUITING

Trial details

NCT number: NCT06373211
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Paraneoplastic Sensory Neuronopathy

Start date: 2025-01-10
Primary completion: 2028-06-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.